DOWNSIDE PERIL(.40, -37%)The downside peril assumes that Urocidin does not receive FDA approval and the value proposition for the Food Safety division does not come to fruition. As such, the downside valuation is based solely on the Animal Health division at 6x C2011E EBITDA. nothing make sens just like war.